RothGAHuffmanMDMoranAE, et al.Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation2015; 132: 1667–1678.
2.
DanchinNAlmahmeedWAl-RasadiK, et al.Management of low-density lipoprotein cholesterol levels: The International Cholesterol Management Practice Study (ICLPS). Eur J Prev Cardiol2018; 25: 1087–1094.
3.
RosselloXDorresteijnJANJanssenA, et al.Risk prediction tools in cardiovascular disease prevention. Eur J Prev Cardiol. 2019; 26: 1534–1544.
4.
TownsendNWilsonLBhatnagarP, et al.Cardiovascular disease in Europe: Epidemiological update 2016. Eur Heart J2016; 37: 3232–3245.
5.
De BacquerDDe BackerG. Predictive ability of the SCORE Belgium risk chart for cardiovascular mortality. Int J Cardiol2010; 143: 385–390.
6.
KarjalainenTAdielsMBjörckL, et al.An evaluation of the performance of SCORE Sweden 2015 in estimating cardiovascular risk. The Northern Sweden MONICA Study 1999–2014. Eur J Prev Cardiol2017; 24: 103–110.
7.
GrundySMStoneNJBaileyAL, et al.2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. Epub ahead of print 3 November 2018. DOI: 10.1016/j.jacc.2018.11.002.
8.
SheridanSLVieraAJKrantzMJ, et al.Cardiovascular Health Intervention Research and Translation Network Work Group on Global Coronary Heart Disease Risk. The effect of giving global coronary risk information to adults: A systematic review. Arch Intern Med2010; 170: 230–239.
9.
VlachopoulosCXaplanterisPAboyansV, et al.The role of vascular biomarkers for primary and secondary prevention. A position paper of the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for research into arterial structure and physiology (ARTERY) Society. Atherosclerosis2015; 241: 507–532.
10.
HallLMLJungRTLeeseGP. Controlled trial of effect of documented cardiovascular disease risk score on prescribing. BMJ2003; 326: 251–251.
11.
SheridanSLBehrendLVuMB, et al.Individuals’ response to global CHD risk: A focus group study. Patient Educ Couns2009; 76: 233–239.
12.
GroverSALowensteynIJosephL, et al.Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: The CHECK-UP Study: A randomized controlled trial. Arch Intern Med2007; 167: 2296–2303.
13.
GroverSALowensteynIJosephL, et al.Discussing coronary risk with patients to improve blood pressure treatment: Secondary results from the CHECK-UP Study. J Gen Intern Med2009; 24: 33–39.
